BONE DESTRUCTION INHIBITOR COMPRISING ANTI-CCL20 ANTIBODY

摘要

The object is to provide a pharmaceutical which is effective for the inhibition of bone destruction. Thus, disclosed is a bone destruction inhibitor which comprises a monoclonal antibody responsive to CCL20 or a fragment of the monoclonal antibody as an active ingredient.